Tscan Therapeutics (TCRX) P/E (2021 - 2026)
Tscan Therapeutics (TCRX) P/E from Jul 16, 2021 to Jul 21, 2026. The TTM Tscan Therapeutics (TCRX) P/E is -0.87. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Tscan Therapeutics (TCRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.87 | -5.96% |
| 2025 | -0.93 | -66.61% |
| 2024 | -2.79 | +12.66% |
| 2023 | -2.47 | +361.49% |
| 2022 | -0.54 | -89.09% |
| 2021 | -4.91 | N/A |
Comparison Tscan Therapeutics (TCRX) P/E with competitors
Tscan Therapeutics (TCRX) P/E is -0.87.